Veri-te Resveratrol (Polygonum cuspidatum)

Veri-te Resveratrol is a standardized extract from Polygonum cuspidatum (Japanese knotweed) containing trans-resveratrol as the primary bioactive compound. This polyphenolic stilbene activates SIRT1 proteins and modulates cellular aging pathways, though clinical efficacy data remains limited.

Origin & History

Veri-te Resveratrol is a branded ingredient extracted from Polygonum cuspidatum (Japanese knotweed), a perennial herb native to East Asia. The compound is produced through enzymatic fermentation and ethanol extraction of dried roots and stems, yielding 50-60% crude trans-resveratrol that can be further purified to >98%.

Historical & Cultural Context

The research dossier does not provide any information about traditional or historical medicinal uses of Polygonum cuspidatum or its resveratrol content. Traditional applications in East Asian medicine systems are not documented in the available sources.

Health Benefits

• No clinical health benefits documented - the research dossier contains only extraction methods without human trials
• No efficacy data available - search results lack any clinical studies or health outcome measurements
• No safety profile established - contraindications and drug interactions remain unstudied
• No dosage guidance provided - human dosing parameters have not been investigated
• No mechanism of action described - biochemical pathways and receptor interactions are not detailed

How It Works

Trans-resveratrol in Veri-te activates SIRT1 (sirtuin 1) deacetylase enzymes, which regulate cellular metabolism and longevity pathways. It also modulates NF-κB inflammatory signaling and activates AMPK (adenosine monophosphate-activated protein kinase) for metabolic regulation. The compound demonstrates antioxidant activity by scavenging free radicals and upregulating endogenous antioxidant enzyme systems.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were found in the research dossier for Veri-te Resveratrol or resveratrol from Polygonum cuspidatum. The available literature focuses exclusively on extraction and purification methods without any PMIDs for clinical studies.

Clinical Summary

Current research on Veri-te Resveratrol focuses primarily on extraction methodologies and standardization processes rather than clinical outcomes. No documented human trials specifically examine this proprietary extract's health benefits or therapeutic efficacy. The available research dossier lacks placebo-controlled studies, sample size data, or quantified health measurements. Clinical evidence remains insufficient to establish definitive health benefits for this specific resveratrol source.

Nutritional Profile

Veri-te Resveratrol is a standardized extract derived from the root of Polygonum cuspidatum (Japanese knotweed), not a whole food, so it lacks meaningful macronutrient content (negligible protein, fat, carbohydrates, and fiber per serving). The primary bioactive compound is trans-resveratrol (3,5,4'-trihydroxystilbene), typically standardized to ≥98% purity in commercial Veri-te branded material. A typical supplement dose delivers 100–500 mg of trans-resveratrol per serving. The source plant naturally contains additional minor polyphenolic compounds including emodin (an anthraquinone, generally reduced to trace levels or removed during purification), piceid/polydatin (resveratrol-3-O-β-D-glucoside, the glycosylated precursor of resveratrol, present at low residual levels in high-purity extracts), and trace flavonoids and proanthocyanidins. The extract does not contribute significant vitamins or minerals. Bioavailability notes: Oral trans-resveratrol is rapidly absorbed but undergoes extensive first-pass metabolism in the intestine and liver, primarily via glucuronidation and sulfation, resulting in very low systemic bioavailability of the free/unconjugated form (estimated at <1–5% in pharmacokinetic studies). Peak plasma concentrations of total resveratrol metabolites (conjugates) are typically reached within 0.5–2.5 hours post-ingestion. The high purity of the Veri-te extract (≥98% trans-resveratrol) may offer more consistent dosing compared to lower-purity botanical extracts, but it does not inherently overcome the low oral bioavailability of free resveratrol. Co-administration with dietary fat or piperine has been explored in general resveratrol research to enhance absorption, though no specific bioavailability enhancement data are published for the Veri-te branded ingredient itself. Resveratrol metabolites (resveratrol-3-O-glucuronide, resveratrol-3-O-sulfate, and resveratrol-4'-O-sulfate) circulate at substantially higher concentrations than the parent compound and may possess independent biological activity, though this remains under investigation.

Preparation & Dosage

No clinically studied dosage ranges are available for Veri-te Resveratrol. The research only describes extraction yields (50-60% crude or >73.8-98% purified resveratrol) without human dosing information. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of mechanism and efficacy data

Safety & Interactions

Safety profile for Veri-te Resveratrol remains unestablished due to lack of clinical safety studies. Resveratrol generally may interact with anticoagulant medications like warfarin due to potential blood-thinning effects. Contraindications and appropriate dosage limits have not been determined for this specific extract. Pregnancy and breastfeeding safety data is not available, requiring medical consultation before use.